EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudieOpen Access · CC BY 4.0

Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results

Kellee M Miller iD, Colleen Bauza iD, Lauren G Kanapka iD, Mark A Clements iD, Daniel J DeSalvo iD, Korey Hood iD, Laurel H Messer iD, Jennifer Sherr iD, Katherine Bergamo iD, Amy Criego iD, Emily Freiner iD, Sarah K Lyons iD und 11 weitere

Pediatric Diabetes · 26.10.2023 · 2023 · 1-12

DOI: 10.1155/2023/6718115 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pediatric Diabetes, erschienen am 26.10.2023. Verfasst von Kellee M Miller und 22 weiteren Autor:innen. Beteiligte Einrichtung: T1D Exchange, St. Petersburg, FL, USA. Hauptthemen laut MEDLINE: Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 1, Glycemic Control. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leona M. and Harry B. Helmsley Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective. To further evaluate glycemic outcomes during the observational extension phase of the Continuous Glucose Monitoring (CGM) Intervention for Teens and Young Adults randomized clinical trial (RCT). Subjects and Methods. Following a 26-week RCT comparing CGM with blood glucose monitoring (BGM) in 153 adolescents and young adults aged 14 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Glycemic ControlAdolescentAdultFemaleHumansMaleYoung AdultContinuous Glucose MonitoringFollow-Up StudiesGlycated HemoglobinHypoglycemic AgentsRandomized Controlled Trials as Topic

Substanzen

Blood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic Agents

Autor:innen und Institutionen

  • T1D Exchange, St. Petersburg, FL, USA.
  • Jaeb Center for Health Research, Tampa, FL, USA.
  • Children's Mercy Hospital, Kansas City, MO, USA.
  • Baylor College of Medicine, Houston, TX, USA.
  • Stanford University, Stanford, CA, USA.
  • Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

ORCID-Profile: Kellee M Miller, Colleen Bauza, Lauren G Kanapka, Mark A Clements, Daniel J DeSalvo, Korey Hood, Laurel H Messer, Jennifer Sherr, Katherine Bergamo, Amy Criego, Emily Freiner, Sarah K Lyons, Roshanak Monzavi, Wayne Moore, Priya Prahalad, Jill H Simmons, Mark Sulik, R Paul Wadwa, Ruth S Weinstock, Steven M Willi, Kristen Williams, Lori M Laffel

Förderung

  • Leona M. and Harry B. Helmsley Charitable Trust

Zitieren

APA

Miller, K. M., Bauza, C., Kanapka, L. G., Clements, M. A., DeSalvo, D. J., Hood, K., Messer, L. H., Sherr, J., Bergamo, K., Criego, A., Freiner, E., Lyons, S. K., Monzavi, R., Moore, W., Prahalad, P., Simmons, J. H., Sulik, M., Wadwa, R. P., Weinstock, R. S., …, & CITY Study Group (2023). Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results. Pediatric Diabetes, 2023, 1-12. https://doi.org/10.1155/2023/6718115

Vancouver

Miller KM, Bauza C, Kanapka LG, Clements MA, DeSalvo DJ, Hood K, et al. Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results. Pediatric Diabetes. 2023;2023:1-12. doi:10.1155/2023/6718115

BibTeX
@article{Miller2023,
  author = {Miller, Kellee M and Bauza, Colleen and Kanapka, Lauren G and Clements, Mark A and DeSalvo, Daniel J and Hood, Korey and Messer, Laurel H and Sherr, Jennifer and Bergamo, Katherine and Criego, Amy and Freiner, Emily and Lyons, Sarah K and Monzavi, Roshanak and Moore, Wayne and Prahalad, Priya and Simmons, Jill H and Sulik, Mark and Wadwa, R Paul and Weinstock, Ruth S and Willi, Steven M and Williams, Kristen and Laffel, Lori M and CITY Study Group, CITY Study Group},
  title = {Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results},
  journal = {Pediatric Diabetes},
  year = {2023},
  volume = {2023},
  pages = {1--12},
  doi = {10.1155/2023/6718115}
}
Kostenlos starten →